Bronchopleural Fistula as a Complication in a COVID-19 Patient Managed With Endobronchial Valves

Bronchopleural fistula (BPF) is associated with high morbidity if left untreated. Although rare, the frequency of BPF in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is becoming recognized in medical literature. We present a case of a 64-year-old male with BPF with persistent air lea...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrew Talon MD (Author), Muhammad Zohab Arif MD (Author), Hesham Mohamed MD (Author), Abid Khokar MD (Author), Ali Imran Saeed MD (Author)
Format: Book
Published: SAGE Publishing, 2021-04-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_359ce939cc744ba3af44ee3669c7ade9
042 |a dc 
100 1 0 |a Andrew Talon MD  |e author 
700 1 0 |a Muhammad Zohab Arif MD  |e author 
700 1 0 |a Hesham Mohamed MD  |e author 
700 1 0 |a Abid Khokar MD  |e author 
700 1 0 |a Ali Imran Saeed MD  |e author 
245 0 0 |a Bronchopleural Fistula as a Complication in a COVID-19 Patient Managed With Endobronchial Valves 
260 |b SAGE Publishing,   |c 2021-04-01T00:00:00Z. 
500 |a 2324-7096 
500 |a 10.1177/23247096211013215 
520 |a Bronchopleural fistula (BPF) is associated with high morbidity if left untreated. Although rare, the frequency of BPF in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is becoming recognized in medical literature. We present a case of a 64-year-old male with BPF with persistent air leak due to SARS-CoV-2 pneumonia treated with Spiration Valve System endobronchial valve (EBV). An EBV was placed in the right middle lobe with successful cessation of air leak. In conclusion, the use of EBVs for BPF with persistent air leaks in SARS-CoV-2 patients who are poor surgical candidates is effective and safe. 
546 |a EN 
690 |a Medicine (General) 
690 |a R5-920 
690 |a Pathology 
690 |a RB1-214 
655 7 |a article  |2 local 
786 0 |n Journal of Investigative Medicine High Impact Case Reports, Vol 9 (2021) 
787 0 |n https://doi.org/10.1177/23247096211013215 
787 0 |n https://doaj.org/toc/2324-7096 
856 4 1 |u https://doaj.org/article/359ce939cc744ba3af44ee3669c7ade9  |z Connect to this object online.